Core Insights - EnWave Corporation will report its financial results for Q3 2025 on August 21, 2025, after market close [1] - A conference call to discuss the results and business outlook is scheduled for August 22, 2025, at 7:00 a.m. Pacific Time [2][3] Company Overview - EnWave is a leader in vacuum microwave dehydration technology, with a strong intellectual property portfolio and a patented Radiant Energy Vacuum (REV™) technology [4] - The company serves various industries, including food, pharmaceuticals, and cannabis, offering a drying solution that outperforms traditional methods in efficiency, capacity, product quality, and cost [4] Business Strategy - EnWave aims to sign royalty-bearing commercial licenses with food producers to enhance their drying processes, achieving optimal moisture levels up to seven times faster than conventional methods [6] - The company has over fifty partners across twenty-four countries, enabling them to create innovative snacks and ingredients while improving existing product quality and market speed [5]

Core Insights - EnWave Corporation will report its financial results for Q3 2025 on August 21, 2025, after market close [1] - A conference call to discuss the results and business outlook is scheduled for August 22, 2025, at 7:00 a.m. Pacific Time [2][3] Company Overview - EnWave is a leader in vacuum microwave dehydration technology, with a strong intellectual property portfolio and a patented Radiant Energy Vacuum (REV™) technology [4] - The company serves various industries, including food, pharmaceuticals, and cannabis, offering a drying solution that outperforms traditional methods in efficiency, capacity, product quality, and cost [4] Business Strategy - EnWave aims to sign royalty-bearing commercial licenses with food producers to enhance drying processes, enabling faster production and improved product quality [6] - The company has over fifty partners across twenty-four countries, helping them create innovative snacks and ingredients while improving existing product offerings [5]

Core Viewpoint - EnWave Corporation has announced a private placement agreement to sell up to 7,500,000 common shares at C$0.40 per share, aiming for gross proceeds of up to C$3,000,000, with a minimum of C$2,000,000 required to proceed with the offering [1][4] Group 1: Offering Details - The offering will be conducted under the Listed Issuer Financing Exemption, allowing shares to be sold without a hold period under Canadian securities laws [2] - The expected closing date for the offering is around August 21, 2025, pending necessary approvals [4] - Clarus Securities Inc. will receive a cash commission of 5.5% of the gross proceeds and non-transferable compensation options equal to 5.5% of the shares sold [5] Group 2: Use of Proceeds - The net proceeds from the offering will be allocated to the construction of two large-scale Radiant Energy Vacuum (REV™) dehydration machines, which will take approximately six months to manufacture [3] Group 3: Company Overview - EnWave is a leader in vacuum microwave dehydration technology, with a strong intellectual property portfolio and a focus on food, pharmaceutical, and cannabis industries [7] - The company has over fifty partners across twenty-four countries, utilizing its technology to create innovative products and improve existing offerings [8] - EnWave's strategy includes signing royalty-bearing commercial licenses with food producers to enhance drying efficiency compared to traditional methods [9]

Company Overview - EnWave Corporation has sold two additional 10kW Radiant Energy Vacuum (REV™) dehydration machines to Dairy Concepts Irl (DCI), marking the fifth and sixth units acquired by DCI [1] - DCI holds an exclusive license to utilize EnWave's proprietary drying technology for producing specific dairy snacks in the UK [1] Product Innovation - DCI specializes in creating high-protein, high-calcium crunchy snacks from Irish cheese, including their CheeseOs™ and Moorepark™ ranges, which feature various flavors and premium cheese options [2][3] - The CheeseOs™ range is made from mild cheddar and includes flavors like salt and vinegar, while the Moorepark™ range uses specialty cheeses such as chilli cheddar and black pepper cheddar [2] Market Performance - DCI has successfully established a market for its innovative snacks, with notable success in Marks and Spencer, leading to further distribution opportunities [3][4] - The company has positioned itself as a leading innovator in the global dairy snacks market by leveraging Ireland's quality dairy ingredients and scientific talent [4] EnWave's Technology and Strategy - EnWave is recognized as a global leader in vacuum microwave dehydration, with a robust intellectual property portfolio and a focus on efficient, scalable drying solutions for various industries [5][6] - The company aims to sign royalty-bearing commercial licenses with food producers, offering benefits such as faster drying times and improved product quality compared to traditional methods [7]

Core Insights - EnWave Corporation has signed an amendment to its royalty-bearing license agreement with Procescir S.A. de C.V., expanding the range of fruit and vegetable products covered under the license [1] - The amendment allows Procescir to capitalize on current commercial opportunities and explore new projects, with the delivery of a 120kW Radiant Energy Vacuum (REV™) machine scheduled for July 2025 [1] - Procescir will commence commercial production of fruit snack products for a prominent American snack brand immediately after the machine's delivery [1] Group 1: Company Developments - The Equipment Purchase Agreement (EPA) signed by Procescir involves the acquisition of auxiliary support equipment for the 120kW REV™ machine, with a transaction amount of approximately CA$170k [2] - Procescir has been operating in Northwest Mexico since 1960 and began commercializing frozen vegetables in 2022 at its processing plant in Hermosillo, Sonora [3] - EnWave is recognized as a leader in vacuum microwave dehydration technology, with a strong intellectual property portfolio and a focus on providing efficient drying solutions across various industries [4][6] Group 2: Market Position and Strategy - EnWave's strategy includes signing royalty-bearing commercial licenses with food producers to enhance drying efficiency compared to traditional methods, enabling faster production and improved product quality [6] - The company has established partnerships with over fifty partners across twenty-four countries, facilitating the creation of innovative snacks and ingredients [5] - EnWave's technology allows producers to achieve optimal moisture levels up to seven times faster, enhancing taste, texture, color, and nutritional value of the products [6]

Core Insights - EnWave Corporation has amended its royalty-bearing license agreement with Creations Foods, allowing the latter to produce dried cheese snacks for pet treat applications in the U.S. on a non-exclusive basis [1] - Creations Foods sees significant growth potential in the pet food industry, with several confirmed customers for pet treats [2] - EnWave is actively seeking new licensed partners in the pet treat and food sector to utilize its REV™ technology for innovative applications [3] Company Overview - Creations Foods is focused on creating unique snack food experiences that are both enjoyable and nutritious, operating a gluten-free facility in Ferndale, Washington [4][5] - EnWave is a leader in vacuum microwave dehydration technology, with a strong intellectual property portfolio and a proven drying solution that outperforms traditional methods [6][8] - EnWave has over fifty royalty-generating partners across twenty-four countries, enabling them to create innovative snacks and improve product quality [7]

Core Viewpoint - EnWave Corporation will report its financial results for Q2 2025 on May 21, 2025, and will hold a conference call to discuss these results on May 22, 2025 [1][2]. Company Overview - EnWave is a leader in vacuum microwave dehydration technology, with a strong intellectual property portfolio and a patented Radiant Energy Vacuum (REV™) technology that offers superior efficiency, capacity, product quality, and cost-effectiveness compared to traditional drying methods [4]. - The company has over fifty partners across twenty-four countries and five continents, enabling the creation of innovative snacks and ingredients while improving existing product quality and market speed [5]. Business Strategy - EnWave's strategy focuses on signing royalty-bearing commercial licenses with food producers to enhance drying processes, allowing for faster moisture level optimization and improved product attributes such as taste, texture, color, and nutritional value [6].

Core Insights - EnWave Corporation has signed a master service agreement with BioTechnique to evaluate EnWave's Radiant Energy Vacuum (REV™) dehydration technology as a potential replacement for lyophilization in the biopharmaceutical industry [1][2] Company Overview - EnWave is a global leader in vacuum microwave dehydration technology, with a robust intellectual property portfolio and a proven, scalable drying solution for food, pharmaceutical, and cannabis industries [5] - The company has over fifty partners across twenty-four countries, utilizing its patented technology to create innovative snacks and ingredients while improving product quality and market efficiency [6] Collaboration Details - The initial collaboration will involve paid testing of several liquid products using pilot-scale REV™ machinery at EnWave's Innovation Center in Delta, British Columbia [2] - If the testing is successful, BioTechnique may acquire its own REV™ equipment to provide services directly to its pharmaceutical clients [2] BioTechnique Overview - BioTechnique is an American pharmaceutical contract manufacturing service provider specializing in therapeutic and highly potent sterile injectable products, both liquid and lyophilized [3] - The company offers a range of services including formulation, compounding, QC testing, temperature-controlled storage, fill-finish, and lyophilization for various injectable products [4]